Severe Heart Failure Treatment : FineHeart Completes its Series B Funding Taking the Total to €21 Million
/
DateDec 15 2021
€6 million of further funds raised in addition to the €15 million in June Clinical trials expected in 2022 BORDEAUX, France–(BUSINESS WIRE)–FineHeart S.A, a preclinical... Read More →



















